Viewing Study NCT04139434

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:39 AM

Ignite Modification Date: 2025-12-31 @ 11:13 PM

Study NCT ID: NCT04139434

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2024-04-24

First Post: 2019-10-18

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

Sponsor: Newave Pharmaceutical Inc

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module